| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 186 |
| 1 | DIAZEPAM ORAL | 185 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 185 |
| 3 | OXYCODONE HYDROCHLORIDE | 95 |
| 4 | INTERFERON BETA-1A | 56 |
| 5 | HYDROMORPHONE HYDROCHLORIDE | 53 |
| 6 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 50 |
| 7 | NILOTINIB | 48 |
| 8 | FINGOLIMOD HCL | 47 |
| 9 | INFLIXIMAB | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIAZEPAM ORAL | 185 | 0.0021 |
| 1 | CLOMIPHENE CITRATE | 3 | 0.0020 |
| 2 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 3 | NILOTINIB | 48 | 0.0016 |
| 4 | DIAZEPAM | 186 | 0.0015 |
| 5 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 3 | 0.0014 |
| 6 | POTASSIUM BICARBONATE | 1 | 0.0014 |
| 7 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 33 | 0.0014 |
| 8 | FOLLITROPIN ALFA | 2 | 0.0010 |
| 9 | THIOGUANINE | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 193 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 63 |
| 2 | Interferon beta [EPC] | 56 |
| 3 | Corticosteroid [EPC] | 48 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 30 |
| 5 | Nucleoside Analog Antiviral [EPC] | 25 |
| 6 | Antirheumatic Agent [EPC] | 22 |
| 7 | Integrin Receptor Antagonist [EPC] | 22 |
| 8 | Vitamin C [EPC] | 19 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | Hedgehog Pathway Inhibitor [EPC] | 3 | 0.0003 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 30 | 0.0003 |
| 4 | Nucleoside Analog Antiviral [EPC] | 25 | 0.0003 |
| 5 | Interferon beta [EPC] | 56 | 0.0003 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 13 | 0.0003 |
| 7 | Antimalarial [EPC] | 3 | 0.0003 |
| 8 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 9 | Benzodiazepine [EPC] | 193 | 0.0003 |